298 related articles for article (PubMed ID: 18226776)
41. Exercise testing in severe emphysema: association with quality of life and lung function.
Brown CD; Benditt JO; Sciurba FC; Lee SM; Criner GJ; Mosenifar Z; Shade DM; Slivka WA; Wise RA;
COPD; 2008 Apr; 5(2):117-24. PubMed ID: 18415810
[TBL] [Abstract][Full Text] [Related]
42. Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg.
García-Talavera I; García CH; Macario CC; de Torres JP; Celli BR; Aguirre-Jaime A
Respir Med; 2008 Jul; 102(7):1026-32. PubMed ID: 18343649
[TBL] [Abstract][Full Text] [Related]
43. Four hundred meters walking test in the evaluation of heart failure patients.
Zdrenghea D; Beudean M; Pop D; Zdrenghea V
Rom J Intern Med; 2010; 48(1):33-8. PubMed ID: 21180238
[TBL] [Abstract][Full Text] [Related]
44. Reference values for the 6-min walk test in healthy subjects 20-50 years old.
Chetta A; Zanini A; Pisi G; Aiello M; Tzani P; Neri M; Olivieri D
Respir Med; 2006 Sep; 100(9):1573-8. PubMed ID: 16466676
[TBL] [Abstract][Full Text] [Related]
45. Reference equations for the six-minute walk distance in the healthy Chinese population aged 18-59 years.
Zou H; Zhu X; Zhang J; Wang Y; Wu X; Liu F; Xie X; Chen X
PLoS One; 2017; 12(9):e0184669. PubMed ID: 28910353
[TBL] [Abstract][Full Text] [Related]
46. Daily walking performance as an independent predictor of advanced heart failure: Prediction of exercise capacity in chronic heart failure.
Jehn M; Schmidt-Trucksäss A; Schuster T; Weis M; Hanssen H; Halle M; Koehler F
Am Heart J; 2009 Feb; 157(2):292-8. PubMed ID: 19185636
[TBL] [Abstract][Full Text] [Related]
47. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST).
Tate CW; Robertson AD; Zolty R; Shakar SF; Lindenfeld J; Wolfel EE; Bristow MR; Lowes BD
J Card Fail; 2007 Nov; 13(9):732-7. PubMed ID: 17996821
[TBL] [Abstract][Full Text] [Related]
48. Six-minute walk distance (6MWD) is associated with body fat, systolic blood pressure, and rate-pressure product in community dwelling elderly subjects.
Wanderley FA; Oliveira J; Mota J; Carvalho MJ
Arch Gerontol Geriatr; 2011; 52(2):206-10. PubMed ID: 20409599
[TBL] [Abstract][Full Text] [Related]
49. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.
Carvalho VO; Ruiz MA; Bocchi EA; Carvalho VO; Guimarães GV
Cardiol J; 2009; 16(5):426-31. PubMed ID: 19753521
[TBL] [Abstract][Full Text] [Related]
50. Effects of inspiratory muscle thixotropy on the 6-min walk distance in COPD.
Izumizaki M; Satake M; Takahashi H; Sugawara K; Shioya T; Homma I
Respir Med; 2008 Jul; 102(7):970-7. PubMed ID: 18396028
[TBL] [Abstract][Full Text] [Related]
51. Can the cardiopulmonary 6-minute walk test reproduce the usual activities of patients with heart failure?
Guimarães GV; Bellotti G; Bacal F; Mocelin A; Bocchi EA
Arq Bras Cardiol; 2002 Jun; 78(6):553-60. PubMed ID: 12185855
[TBL] [Abstract][Full Text] [Related]
52. Reference values for the 6-Min Walking Test in obese subjects.
Capodaglio P; De Souza SA; Parisio C; Precilios H; Vismara L; Cimolin V; Brunani A
Disabil Rehabil; 2013 Jul; 35(14):1199-203. PubMed ID: 23061440
[TBL] [Abstract][Full Text] [Related]
53. Six-minute walk test in patients with permanent cardiac pacemakers.
Pereira de Sousa LA; Britto RR; Ribeiro AL; Baracho SM; da Costa Val Barros V; Carvalho VT; Parreira VF
J Cardiopulm Rehabil Prev; 2008; 28(4):253-7. PubMed ID: 18628656
[TBL] [Abstract][Full Text] [Related]
54. [Six-minute walking test for the evaluation of the status of patients with chronic cardiac failure].
Perepech NB; Kutuzova AE; Nedoshivin AO
Klin Med (Mosk); 2000; 78(12):31-3. PubMed ID: 11210348
[TBL] [Abstract][Full Text] [Related]
55. [The usefulness of the 6-minute walk test in patients with chronic heart failure in 6-month observation].
Krauze-Wielicka M; Kasperczyk S; Przywara B; Fudal M; Lesik D; Gromnicka E; Dalecka E; Simońska E
Wiad Lek; 2005; 58(5-6):280-3. PubMed ID: 16238117
[TBL] [Abstract][Full Text] [Related]
56. Six minute walk test Z score: correlations with cystic fibrosis severity markers.
Stollar F; Rodrigues JC; Cunha MT; Leone C; Adde FV
J Cyst Fibros; 2012 May; 11(3):253-6. PubMed ID: 22188977
[TBL] [Abstract][Full Text] [Related]
57. The 6-minute walk test: normal values for children of 4-11 years of age.
Lammers AE; Hislop AA; Flynn Y; Haworth SG
Arch Dis Child; 2008 Jun; 93(6):464-8. PubMed ID: 17675356
[TBL] [Abstract][Full Text] [Related]
58. Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failure.
Tabata M; Shimizu R; Kamekawa D; Kato M; Kamiya K; Akiyama A; Kamada Y; Tanaka S; Noda C; Masuda T
Int Heart J; 2014; 55(4):331-6. PubMed ID: 24898596
[TBL] [Abstract][Full Text] [Related]
59. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy.
Castel MA; Méndez F; Tamborero D; Mont L; Magnani S; Tolosana JM; Berruezo A; Godoy M; Sitges M; Vidal B; Roig E; Brugada J
Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491
[TBL] [Abstract][Full Text] [Related]
60. Repeat six-minute walk tests in patients with chronic heart failure: are they clinically necessary?
Adsett J; Mullins R; Hwang R; Hogden A; Gibson E; Houlihan K; Tuppin M; Korczyk D; Mallitt KA; Mudge A
Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):601-6. PubMed ID: 21450639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
